BioVie Inc. (BIVI) stock
BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
$1.00−0.08 (-7.84%)
Close on Nov 17, 2026Market cap $7.51MP/E –Yield –
BioVie total assets
Total assets on the balance sheet at the end of each period.
BioVie's total assets was $14.25M at Jun 30, 2026. For fiscal 2026 it was $14.25M, down 33.9% from the year before. Over ten years it grew 18.0% a year on average. The highest annual figure on record is $35.10M in fiscal 2023.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $14.25M | -33.9% |
| FY2025 | Jun 30, 2025 | $21.56M | -14.5% |
| FY2024 | Jun 30, 2024 | $25.21M | -28.2% |
| FY2023 | Jun 30, 2023 | $35.10M | +74.5% |
| FY2022 | Jun 30, 2022 | $20.11M | +232.7% |
| FY2021 | Jun 30, 2021 | $6.05M | +190.2% |
| FY2020 | Jun 30, 2020 | $2.08M | -19.1% |
| FY2019 | Jun 30, 2019 | $2.57M | +18.3% |
| FY2018 | Jun 30, 2018 | $2.18M | -8.0% |
| FY2017 | Jun 30, 2017 | $2.36M | -13.1% |
| FY2016 | Jun 30, 2016 | $2.72M | +909.0% |
| FY2015 | Jun 30, 2015 | $269.48K | -19.0% |
| FY2014 | Jun 30, 2014 | $332.86K | -34.2% |
| FY2013 | Jun 30, 2013 | $505.70K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $14.25M | -33.9% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $17.51M | -29.0% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $22.50M | -12.4% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $26.82M | +26.3% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $21.56M | -14.5% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $24.66M | -22.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $25.69M | +19.6% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $21.24M | -10.6% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $25.21M | -28.2% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $31.77M | -29.7% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $21.49M | -54.5% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $23.76M | +3.9% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $35.10M | +74.5% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $45.18M | +72.5% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $47.19M | +48.1% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $22.86M | +4.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $20.11M | +232.7% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $26.19M | +103.1% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $31.87M | +136.8% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $21.98M | +47.9% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $6.05M | +190.2% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $12.89M | +458.3% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $13.46M | +475.3% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $14.86M | +469.8% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $2.08M | -19.1% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $2.31M | -36.7% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $2.34M | +7.5% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $2.61M | +17.8% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $2.57M | +14.6% |
| Q1 FY2019CQ3 2018 | Dec 31, 2018 | $3.65M | +56.9% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $2.18M | -8.0% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $2.22M | -9.7% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $2.25M | -9.4% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $2.32M | -8.5% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $2.36M | -13.1% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $2.45M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $2.48M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $2.54M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $2.72M | – |
See a number that looks wrong?